Hemostats Market - Global Forecast to 2028
商品番号 : SMB-4385
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 262 |
| 図表数 | 290 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、ヘモスタシス(止血剤)市場を分析し、エンドユーザー、地域、用途、種類、製剤など、様々なセグメントにおける市場規模と将来の成長可能性を予測しています。さらに、主要企業の競合分析も掲載しており、企業概要、製品ラインナップ、最近の動向、主要な市場戦略を詳細に解説しています。
The global hemostats market is projected to reach 4.0 billion in 2030 from USD 2.9 billion in 2025, at a CAGR of 6.4% during the forecast period.
世界のヘモスタシス(止血剤)市場は、予測期間中に6.4%のCAGRで成長し、2025年の29億米ドルから2030年には40億米ドルに達すると予測されています。
The escalating demographic of the elderly is driving a significant uptick in the demand for surgical interventions, highlighting the pivotal role of hemostatic agents within modern healthcare. As individuals age, they become more susceptible to a range of chronic conditions necessitating surgical correction to restore or improve functional capacity. This includes procedures such as orthopedic joint replacements and more complex cardiovascular and gastrointestinal surgeries. Aging is associated with physiological changes, including diminished tissue resilience and an elevated propensity for hemorrhage. Consequently, the judicious application of hemostatic agents is critical for optimizing surgical outcomes in geriatric patients. With the global aging population on the rise, the demand for hemostatic products is projected to escalate correspondingly, underscoring their essential contribution to addressing the intricate surgical care requirements of older adults. Nonetheless, the prohibitive costs of advanced hemostatic technologies coupled with limited accessibility in resource-constrained environments may pose challenges to their broader implementation.
高齢者人口の増加は外科的介入の需要の大幅な増加を促進しており、現代の医療において止血剤が極めて重要な役割を担っていることを浮き彫りにしています。年齢を重ねるにつれて、機能能力を回復または改善するために外科的矯正を必要とするさまざまな慢性疾患にかかりやすくなり、整形外科的な関節置換術や、より複雑な心血管および消化器の手術などが含まれます。加齢は、組織の弾力性の低下や出血傾向の上昇など、生理学的変化を伴います。したがって、高齢患者の手術結果を最適化するには、止血剤を慎重に適用することが重要です。世界中で高齢化が進むにつれて、止血製品の需要もそれに応じて増加すると予測されており、高齢者の複雑な外科治療のニーズに対応する上で止血剤が不可欠な貢献をすることが強調されています。しかしながら、高度な止血技術の法外なコストと、資源が限られた環境でのアクセスの制限が相まって、その広範な導入には課題が生じる可能性があります。

“Combination hemostats segment accounted for the highest growth rate in the hemostats market, by type, during the study period.”
The hemostats market is bifurcated into oxidized regenerated cellulose-based hemostats, thrombin-based hemostats, combination hemostats, gelatin-based hemostats, collagen-based hemostats, and other hemostats on the basis of type. The market for hemostatic agents is experiencing rapid growth due to the superior efficacy of combination hemostats compared to monotherapy products. These advanced hemostatic agents operate through multiple mechanisms, which enhance their ability to control surgical hemorrhage effectively. Key benefits associated with these combination products include decreased intraoperative blood loss, expedited and reliable hemostasis, reduced convalescence times, and a lower frequency of transfusion requirements. Furthermore, the implementation of combination hemostats has been linked to improved patient outcomes, such as shortened hospital stays and faster recovery trajectories.
“Sponge hemostats segment accounted for the highest growth rate in the hemostats market, by formulation, during the forecast period.”
The global hemostats market is bifurcated into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. The sponge hemostats segment is experiencing the most rapid growth due to an increasing reliance on sponge-based formulations among surgeons and healthcare professionals, attributed to several key advantages. These hemostatic sponges are highly absorbent, user-friendly, and conform well to irregular wound geometries, making them applicable to a wide range of surgical procedures. They facilitate prompt hemostasis, mitigate the risk of postoperative bleeding, and are frequently available in ready-to-use formats, eliminating the need for prior preparation. Furthermore, most sponge hemostats are bioresorbable, which removes the necessity for subsequent removal and minimizes potential complications. Recent advancements in material science have led to the development of sponge hemostats with enhanced biocompatibility and antimicrobial properties, further solidifying their clinical preference. These innovations not only improve the safety profile but also optimize their effectiveness in various surgical contexts.
“By application, the orthopedic surgery segment accounted for the largest share of the hemostats market in 2024.”
The hemostats market has been segmented into orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, gynecological surgery, reconstructive surgery, and other surgical applications, based on application. In 2024, the orthopedic surgery segment dominated the hemostats market, a trend driven by a rising prevalence of lifestyle-related conditions such as arthritis, osteoporosis, and obesity, which often lead to musculoskeletal complications requiring surgical intervention. The demographic shift towards an aging population, which is more susceptible to degenerative bone and joint disorders, also significantly contributes to the increased demand for orthopedic surgical procedures. Moreover, the escalating incidence of sports-related injuries and traumatic fractures necessitates a more substantial number of surgical interventions where precise hemostatic control is crucial. The growing preference for minimally invasive orthopedic techniques, which prioritize effective hemostasis without compromising clinical outcomes, further fuels market demand. Additionally, improved healthcare accessibility in emerging markets, coupled with the availability of advanced hemostatic agents, is facilitating the broader adoption of these products in orthopedic surgical practices.
“By region, the Asia Pacific was the fastest-growing region in the hemostats market in 2024.”
The global hemostats market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is poised for significant growth in the hemostats market over the forecast period, primarily driven by robust GDP growth and rising disposable incomes in emerging economies. These economic dynamics are facilitating increased healthcare expenditure among broader demographics. The demand for sophisticated surgical products, such as hemostats, is escalating due to a surge in surgical procedures, a higher prevalence of chronic diseases, and the ongoing modernization of healthcare infrastructures. Moreover, the market is propelled by the increasing integration of advanced medical technologies, extending even into rural areas. The rapid expansion of healthcare facilities, particularly hospitals and clinics in China and India, combined with government initiatives to enhance disease management awareness, are critical contributors to this growth. Additionally, the significant uptick in healthcare spending across numerous Asian nations has bolstered the purchasing power of healthcare providers, thereby expediting the adoption of innovative hemostatic agents within the region.
The break-up of the profile of primary participants in the hemostats market:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level – 27%, Director-level – 18%, and Others – 55%
- By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%
Prominent players in the hemostats market include Johnson & Johnson Services, Inc. (US), Baxter (US), Pfizer Inc. (US), B. Braun SE (Germany), BD (US), Teleflex Incorporated (US), Medtronic (Ireland), Hemostasis, LLC (US), Stryker ((US), Integra LifeSciences Corporation (US), Advanced Medical Solutions Group plc (UK), Samyang Corporation (South Korea), Marine Polymer Technologies, Inc. (US), GELITA MEDICAL (Germany), Dilon Technologies (US), Betatech Medical (Turkey), Meril Life Sciences Pvt. Ltd. (India), BioCer Development GmbH (Germany), Unilene (Peru), Katsan Medical Devices (Turkey), Tricol Biomedical (US), 3-D Matrix Medical Technology (Japan), Hemostat Medical GmbH (Germany), CELOX Medical Ltd. (UK), and Altaylar Medical (Turkey).

Research Coverage
The report analyzes the hemostats market, estimating the market size and potential for future growth across various segments, including end users, regions, applications, type, and formulation. Additionally, the report features a competitive analysis of the key players in the market, detailing their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report provides valuable insights for market leaders and new entrants in the hemostats industry, offering approximate revenue figures for the overall market and its subsegments. It assists stakeholders in understanding the competitive landscape, enabling them to position their businesses better and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, helping stakeholders gauge the current state of the market.
This report provides insights into the following pointers:
Analysis of key drivers (growing volume of surgical procedures performed, rising focus on R&D, and increasing emphasis on effective blood loss management in patients during surgeries), restraints (side effects and allergic reactions associated with hemostats), opportunities (increasing growth opportunities in emerging economies), and challenges (stringent regulatory framework, dearth of skilled personnel for effective use of hemostats, and high cost of hemostats) influencing the growth of the hemostats market.
- Market Penetration: It provides detailed information on the product portfolios that major players in the global hemostats market offer. The report covers various segments: end user, region, application, type, and formulation.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global hemostats market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the hemostats market across varied regions.
- Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global hemostats market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global hemostats market.
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 INCLUSIONS & EXCLUSIONS 27
1.4 YEARS CONSIDERED 28
1.5 UNIT CONSIDERED 28
1.5.1 CURRENCY/VALUE UNIT 28
1.5.2 VOLUME CONSIDERED 29
1.6 STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key insights from industry experts 34
2.1.2.3 Breakdown of primary profiles 35
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 36
2.2.2 TOP-DOWN APPROACH 37
2.2.2.1 Estimating market size using top-down approach 37
2.2.3 SUPPLY-SIDE ANALYSIS 38
2.3 DATA TRIANGULATION 39
2.4 RESEARCH ASSUMPTIONS 40
2.5 RESEARCH LIMITATIONS 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 45
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN TEXTURED VEGETABLE MARKET 45
4.2 NORTH AMERICAN TEXTURED VEGETABLE PROTEIN MARKET,
BY SOURCE AND COUNTRY 46
4.3 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE (VOLUME) 46
4.4 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE AND REGION 47
4.5 TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MACROECONOMIC INDICATORS 49
5.2.1 GLOBAL PRODUCTION OF PEA CROPS AND GREEN PEAS 49
5.2.2 GROWING HEALTH TRENDS 50
5.2.3 CONSUMER SHIFT TOWARD PLANT-BASED NUTRITION 51
5.3 MARKET DYNAMICS 52
5.3.1 DRIVERS 53
5.3.1.1 Growing demand for meat alternatives 53
5.3.1.2 Breakthroughs in food science and processing technologies 54
5.3.1.3 Surge in investments and collaborations in plant-sourced food business 54
5.3.2 RESTRAINTS 55
5.3.2.1 Allergies associated with vegetable protein sources 55
5.3.2.2 Complexities in processing textured vegetable proteins 55
5.3.3 OPPORTUNITIES 56
5.3.3.1 Economical solutions using plant-based ingredients 56
5.3.3.2 Shift from traditional extraction sources of textured vegetable protein to new sources 57
5.3.4 CHALLENGES 57
5.3.4.1 Stringent government regulations 57
5.3.4.2 High cost of production 58
5.4 IMPACT OF GENERATIVE AI/AI ON TEXTURED VEGETABLE PROTEIN MARKET 58
5.4.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS 59
5.4.2 CASE STUDY ANALYSIS 60
5.4.2.1 AI Bobby: Optimizing Protein Gelation 60
5.4.2.2 GreenProtein AI: Extrusion Optimization 60
5.4.2.3 Cradle: Designing Novel TVP Proteins 60
5.4.3 IMPACT OF AI ON TEXTURED VEGETABLE PROTEIN MARKET 61
5.4.4 IMPACT OF GEN AI ON ADJACENT ECOSYSTEM 61
6 TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE 62
6.1 INTRODUCTION 63
6.2 SLICES 64
6.2.1 CHANGING LIFESTYLE AND INCREASING HEALTH AWARENESS TO BOOST DEMAND FOR TVP SLICES AS MEAT SUBSTITUTE 64
6.3 FLAKES 65
6.3.1 HIGH PROTEIN AND LOW FATS IN TEXTURED VEGETABLE PROTEIN FLAKES TO DRIVE MARKET 65
6.4 CHUNKS 66
6.4.1 CUSTOMIZABLE FLAVOR OPTIONS TO ADD TO POPULARITY OF TEXTURED VEGETABLE PROTEIN CHUNKS 66
6.5 GRANULES 68
6.5.1 USE OF GRANULES AS MEAT EXTENDERS AND EASY STORING OPTIONS TO DRIVE MARKET 68
7 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE 69
7.1 INTRODUCTION 70
7.2 SOY 72
7.2.1 HIGH SHELF-LIFE AND LOW CALORIES IN SOYMEAL PRODUCTS TO BOOST DEMAND 72
7.3 PEA 74
7.3.1 USE OF TEXTURED PEA PROTEIN IN DIFFERENT PRODUCTS TO DRIVE MARKET 74
7.4 WHEAT 76
7.4.1 EXCELLENT BINDING CHARACTERISTICS OF WHEAT TO INCREASE ITS USAGE IN ALTERNATIVE MEAT PRODUCTS 76
7.5 OTHER SOURCES 77
8 TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION 80
8.1 INTRODUCTION 81
8.2 MEAT ANALOGUES 82
8.2.1 INCREASING USE OF MEAT ALTERNATIVES IN VARIOUS FOOD APPLICATIONS TO DRIVE MARKET 82
8.3 READY-TO-EAT MEALS 83
8.3.1 CONSUMER PREFERENCE FOR CONVENIENCE, NUTRITION, AND SUSTAINABILITY IN FOOD CHOICES TO DRIVE MARKET 83
8.4 BARS & SNACKS 85
8.4.1 HEALTHY SNACKING HABITS TO DRIVE PARADIGM SHIFT IN CONSUMER BEHAVIOR FOR TEXTURED PROTEINS 85
8.5 OTHER APPLICATIONS 87
9 TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE 89
9.1 INTRODUCTION 90
9.2 ORGANIC 91
9.2.1 AVAILABILITY OF LOW-COST ORGANIC PROTEIN TO INCREASE DEMAND FOR ORGANIC TEXTURED VEGETABLE PROTEIN 91
9.3 CONVENTIONAL 92
9.3.1 GROWTH OF CONVENTIONAL FARMING DUE TO LOW POPULARITY OF ORGANIC FARMING TO FOSTER MARKET GROWTH 92
10 TEXTURED VEGETABLE PROTEIN MARKET, BY REGION 93
10.1 INTRODUCTION 94
10.2 NORTH AMERICA 97
10.2.1 US 103
10.2.1.1 Need to enhance production capacity and meet rising consumer demand for innovative plant-based options to drive market 103
10.2.2 CANADA 104
10.2.2.1 Increasing awareness about functional health benefits of healthier diet to drive market 104
10.2.3 MEXICO 106
10.2.3.1 Changing consumer preferences toward vegan products to drive market 106
10.3 EUROPE 107
10.3.1 GERMANY 112
10.3.1.1 Growing concerns over sustainability and increasing vegan population to drive market 112
10.3.2 UK 113
10.3.2.1 Increasing government investments in plant-based protein to fuel demand for textured vegetable proteins 113
10.3.3 FRANCE 114
10.3.3.1 Collaboration between different stakeholders in plant-based protein industry to drive market 114
10.3.4 ITALY 115
10.3.4.1 Shifting opinion on meat consumption toward sustainable alternatives to boost demand for textured vegetable proteins 115
10.3.5 SPAIN 116
10.3.5.1 Rising demand for meat alternatives due to growing inclination toward nutritious food to drive market 116
10.3.6 REST OF EUROPE 117
10.4 ASIA PACIFIC 118
10.4.1 CHINA 124
10.4.1.1 Higher production capabilities and cheap labor to boost market 124
10.4.2 INDIA 125
10.4.2.1 Influence of Western culture to fuel vegan trends and result in increased demand for textured vegetable protein 125
10.4.3 JAPAN 126
10.4.3.1 Rise in awareness surrounding meat processing and health concerns to boost market 126
10.4.4 AUSTRALIA AND NEW ZEALAND 128
10.4.4.1 Consumer preferences and sustainability to accelerate market growth 128
10.4.5 REST OF ASIA PACIFIC 129
10.5 SOUTH AMERICA 130
10.5.1 BRAZIL 135
10.5.1.1 Rising veganism trend and increasing awareness of health and environmental issues to trigger market growth 135
10.5.2 ARGENTINA 136
10.5.2.1 Rising funding and growing environmental and animal welfare concerns in plant-based protein industry to fuel market growth 136
10.5.3 REST OF SOUTH AMERICA 137
10.6 REST OF THE WORLD 138
10.6.1 MIDDLE EAST 143
10.6.1.1 Need for plant-based protein and presence of global players to drive market 143
10.6.2 AFRICA 144
10.6.2.1 Growing awareness and adoption of plant-based protein to boost market for textured vegetable protein 144
11 COMPETITIVE LANDSCAPE 146
11.1 OVERVIEW 146
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 146
11.3 REVENUE ANALYSIS, 2022–2024 148
11.4 MARKET SHARE ANALYSIS 149
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 152
11.5.1 STARS 152
11.5.2 EMERGING LEADERS 152
11.5.3 PERVASIVE PLAYERS 152
11.5.4 PARTICIPANTS 152
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 154
11.5.5.1 Company footprint 154
11.5.5.2 Type footprint 155
11.5.5.3 Nature footprint 156
11.5.5.4 Application footprint 157
11.5.5.5 Regional footprint 158
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024 159
11.6.1 PROGRESSIVE COMPANIES 159
11.6.2 RESPONSIVE COMPANIES 159
11.6.3 DYNAMIC COMPANIES 159
11.6.4 STARTING BLOCKS 159
11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024 161
11.6.5.1 Detailed list of key start-ups/SMEs 161
11.6.5.2 Competitive benchmarking of key start-ups/SMEs 162
11.7 COMPANY VALUATION AND FINANCIAL METRICS 163
11.8 BRAND/PRODUCT COMPARISON 164
11.9 COMPETITIVE SCENARIO AND TRENDS 165
11.9.1 PRODUCT LAUNCHES 165
11.9.2 DEALS 167
11.9.3 EXPANSIONS 168
12 COMPANY PROFILES 171
12.1 KEY PLAYERS 171
12.1.1 ADM 171
12.1.1.1 Business overview 171
12.1.1.2 Product/Solutions/Services offered 172
12.1.1.3 Recent developments 173
12.1.1.3.1 Product launches 173
12.1.1.3.2 Deals 174
12.1.1.3.3 Expansions 174
12.1.1.4 MnM view 174
12.1.1.4.1 Right to win 174
12.1.1.4.2 Strategic choices 174
12.1.1.4.3 Weaknesses and competitive threats 175
12.1.2 CARGILL, INCORPORATED 176
12.1.2.1 Business overview 176
12.1.2.2 Products/Solutions/Services offered 177
12.1.2.3 Recent developments 177
12.1.2.3.1 Product launches 177
12.1.2.3.2 Expansions 177
12.1.2.4 MnM view 178
12.1.2.4.1 Right to win 178
12.1.2.4.2 Strategic choices 178
12.1.2.4.3 Weaknesses and competitive threats 178
12.1.3 ROQUETTE FRÈRES 179
12.1.3.1 Business overview 179
12.1.3.2 Products/Solutions/Services offered 180
12.1.3.3 Recent developments 180
12.1.3.3.1 Product launches 180
12.1.3.3.2 Deals 181
12.1.3.3.3 Expansions 181
12.1.3.4 MnM view 182
12.1.3.4.1 Right to win 182
12.1.3.4.2 Strategic choices 182
12.1.3.4.3 Weaknesses and competitive threats 182
12.1.4 INTERNATIONAL FLAVORS & FRAGRANCES INC. 183
12.1.4.1 Business overview 183
12.1.4.2 Products/Solutions/Services offered 184
12.1.4.3 Recent developments 185
12.1.4.3.1 Product launches 185
12.1.4.3.2 Deals 185
12.1.4.4 MnM view 185
12.1.4.4.1 Right to win 185
12.1.4.4.2 Strategic choices 186
12.1.4.4.3 Weaknesses and competitive threats 186
12.1.5 INGREDION 187
12.1.5.1 Business overview 187
12.1.5.2 Products/Solutions/Services offered 188
12.1.5.3 Recent developments 189
12.1.5.3.1 Product launches 189
12.1.5.3.2 Deals 189
12.1.5.4 MnM view 190
12.1.5.4.1 Right to win 190
12.1.5.4.2 Strategic choices 190
12.1.5.4.3 Weaknesses and competitive threats 190
12.1.6 DSM-FIRMENICH 191
12.1.6.1 Business overview 191
12.1.6.2 Products/Solutions/Services offered 192
12.1.6.3 Recent developments 193
12.1.6.3.1 Product launches 193
12.1.6.3.2 Deals 193
12.1.6.4 MnM view 193
12.1.7 MGP 194
12.1.7.1 Business overview 194
12.1.7.2 Products/Solutions/Services offered 195
12.1.7.3 Recent developments 196
12.1.7.3.1 Product launches 196
12.1.7.3.2 Expansions 196
12.1.7.4 MnM view 197
12.1.8 PURIS 198
12.1.8.1 Business overview 198
12.1.8.2 Products/Solutions/Services offered 198
12.1.8.3 Recent developments 199
12.1.8.3.1 Product launches 199
12.1.8.3.2 Expansions 199
12.1.8.4 MnM view 200
12.1.9 BENEO 201
12.1.9.1 Business overview 201
12.1.9.2 Products/Solutions/Services offered 201
12.1.9.3 Recent developments 202
12.1.9.3.1 Deals 202
12.1.9.3.2 Expansions 202
12.1.9.4 MnM view 203
12.1.10 AXIOM FOODS, INC. 204
12.1.10.1 Business overview 204
12.1.10.2 Products/Solutions/Services offered 204
12.1.10.3 Recent developments 205
12.1.10.3.1 Product launches 205
12.1.10.4 MnM view 205
12.1.11 THE SCOULAR COMPANY 206
12.1.11.1 Business overview 206
12.1.11.2 Products/Solutions/Services offered 206
12.1.11.3 MnM view 206
12.1.12 SHANDONG YUXIN BIO-TECH CO., LTD. 207
12.1.12.1 Business overview 207
12.1.12.2 Products/Solutions/Services offered 207
12.1.12.3 MnM view 207
12.1.13 GUSHEN BIOLOGICAL TECHNOLOGY GROUP CO., LTD. 208
12.1.13.1 Business overview 208
12.1.13.2 Products/Solutions/Services offered 208
12.1.13.3 MnM view 208
12.1.14 FOODCHEM INTERNATIONAL CORPORATION 209
12.1.14.1 Business overview 209
12.1.14.2 Products/Solutions/Services offered 209
12.1.14.3 MnM view 209
12.1.15 DACSA GROUP 210
12.1.15.1 Business overview 210
12.1.15.2 Products/Solutions/Services offered 210
12.1.15.3 MnM view 211
12.2 OTHER PLAYERS 212
12.2.1 SHANDONG WONDERFUL BIOTECH CO., LTD. 212
12.2.1.1 Business overview 212
12.2.1.2 Products/Solutions/Services offered 212
12.2.1.3 MnM view 212
12.2.2 SUN NUTRAFOODS 214
12.2.2.1 Business overview 214
12.2.2.2 Products/Solutions/Services offered 214
12.2.2.3 MnM view 214
12.2.3 CROWN SOYA PROTEIN GROUP COMPANY 215
12.2.3.1 Business overview 215
12.2.3.2 Products/Solutions/Services offered 215
12.2.3.3 MnM view 215
12.2.4 HOYA FOODS 216
12.2.4.1 Business overview 216
12.2.4.2 Products/Solutions/Services offered 216
12.2.4.3 MnM view 217
12.2.5 SOTEXPRO 218
12.2.5.1 Business overview 218
12.2.5.2 Products/Solutions/Services offered 218
12.2.5.3 MnM view 218
12.2.6 LIVING FOODS 219
12.2.7 PRANA ORGANIC 219
12.2.8 ND LABS INC 220
12.2.9 BLATTMANN SCHWEIZ AG 220
12.2.10 SONIC BIOCHEM 221
13 ADJACENT AND RELATED MARKETS 222
13.1 INTRODUCTION 222
13.2 LIMITATIONS 222
13.3 PLANT-BASED PROTEIN MARKET 222
13.3.1 MARKET DEFINITION 222
13.3.2 MARKET OVERVIEW 223
13.4 PEA PROTEIN MARKET 225
13.4.1 MARKET DEFINITION 225
13.4.2 MARKET OVERVIEW 226
13.5 MEAT SUBSTITUTES MARKET 227
13.5.1 MARKET DEFINITION 227
13.5.2 MARKET OVERVIEW 228
14 APPENDIX 229
14.1 DISCUSSION GUIDE 229
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 233
14.3 CUSTOMIZATION OPTIONS 235
14.4 RELATED REPORTS 235
14.5 AUTHOR DETAILS 236
LIST OF TABLES
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2020–2024 29
TABLE 2 TEXTURED VEGETABLE PROTEIN MARKET SNAPSHOT, 2025 VS. 2030 41
TABLE 3 TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE, 2020–2024 (USD MILLION) 64
TABLE 4 TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE, 2025–2030 (USD MILLION) 64
TABLE 5 SLICES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 65
TABLE 6 SLICES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 65
TABLE 7 FLAKES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 66
TABLE 8 FLAKES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 66
TABLE 9 CHUNKS: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 67
TABLE 10 CHUNKS: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 67
TABLE 11 GRANULES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 68
TABLE 12 GRANULES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 68
TABLE 13 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (USD MILLION) 71
TABLE 14 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (USD MILLION) 71
TABLE 15 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE, 2020–2024 (KILOTON) 71
TABLE 16 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE, 2025–2030 (KILOTON) 71
TABLE 17 SOY: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 72
TABLE 18 SOY: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 73
TABLE 19 SOY: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (KILOTON) 73
TABLE 20 SOY: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (KILOTON) 73
TABLE 21 PEA: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 74
TABLE 22 PEA: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 75
TABLE 23 PEA: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (KILOTON) 75
TABLE 24 PEA: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (KILOTON) 75
TABLE 25 WHEAT: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 76
TABLE 26 WHEAT: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 76
TABLE 27 WHEAT: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (KILOTON) 77
TABLE 28 WHEAT: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (KILOTON) 77
TABLE 29 OTHER SOURCES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 78
TABLE 30 OTHER SOURCES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 78
TABLE 31 OTHER SOURCES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (KILOTON) 79
TABLE 32 OTHER SOURCES: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (KILOTON) 79
TABLE 33 TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 82
TABLE 34 TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 82
TABLE 35 MEAT ANALOGUES: TEXTURIZED VEGETABLE PROTEIN MARKET, BY REGION, 2020–2024 (USD MILLION) 83
TABLE 36 MEAT ANALOGUES: TEXTURIZED VEGETABLE PROTEIN MARKET, BY REGION, 2025–2030 (USD MILLION) 83
TABLE 37 READY-TO-EAT MEALS: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION, 2020–2024 (USD MILLION) 84
TABLE 38 READY-TO-EAT MEALS: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION, 2025–2030 (USD MILLION) 85
TABLE 39 BARS & SNACKS: TEXTURIZED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 86
TABLE 40 BARS & SNACKS: TEXTURIZED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 86
TABLE 41 OTHER APPLICATIONS: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION, 2020–2024 (USD MILLION) 87
TABLE 42 OTHER APPLICATIONS: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION, 2025–2030 (USD MILLION) 88
TABLE 43 TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE, 2020–2024 (USD MILLION) 90
TABLE 44 TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE, 2025–2030 (USD MILLION) 90
TABLE 45 ORGANIC: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 91
TABLE 46 ORGANIC: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 91
TABLE 47 CONVENTIONAL: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2020–2024 (USD MILLION) 92
TABLE 48 CONVENTIONAL: TEXTURED VEGETABLE PROTEIN MARKET, BY REGION,
2025–2030 (USD MILLION) 92
TABLE 49 TEXTURED VEGETABLE PROTEIN MARKET, BY REGION, 2020–2024 (USD MILLION) 95
TABLE 50 TEXTURED VEGETABLE PROTEIN MARKET, BY REGION, 2025–2030 (USD MILLION) 96
TABLE 51 TEXTURED VEGETABLE PROTEIN MARKET, BY REGION, 2020–2024 (KILOTON) 96
TABLE 52 TEXTURED VEGETABLE PROTEIN MARKET, BY REGION, 2025–2030 (KILOTON) 96
TABLE 53 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 98
TABLE 54 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 99
TABLE 55 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (KILOTON) 99
TABLE 56 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (KILOTON) 99
TABLE 57 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2020–2024 (USD MILLION) 100
TABLE 58 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2025–2030 (USD MILLION) 100
TABLE 59 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (USD MILLION) 100
TABLE 60 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (USD MILLION) 101
TABLE 61 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (KILOTON) 101
TABLE 62 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (KILOTON) 101
TABLE 63 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 102
TABLE 64 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 102
TABLE 65 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2020–2024 (USD MILLION) 102
TABLE 66 NORTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2025–2030 (USD MILLION) 103
TABLE 67 US: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 104
TABLE 68 US: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 104
TABLE 69 CANADA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 105
TABLE 70 CANADA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 105
TABLE 71 MEXICO: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 106
TABLE 72 MEXICO: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 106
TABLE 73 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 107
TABLE 74 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 108
TABLE 75 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (KILOTON) 108
TABLE 76 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (KILOTON) 108
TABLE 77 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2020–2024 (USD MILLION) 109
TABLE 78 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2025–2030 (USD MILLION) 109
TABLE 79 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (USD MILLION) 109
TABLE 80 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (USD MILLION) 110
TABLE 81 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (KILOTON) 110
TABLE 82 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (KILOTON) 110
TABLE 83 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 111
TABLE 84 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 111
TABLE 85 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2020–2024 (USD MILLION) 111
TABLE 86 EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2025–2030 (USD MILLION) 112
TABLE 87 GERMANY: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 113
TABLE 88 GERMANY: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 113
TABLE 89 UK: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 114
TABLE 90 UK: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 114
TABLE 91 FRANCE: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 115
TABLE 92 FRANCE: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 115
TABLE 93 ITALY: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 116
TABLE 94 ITALY: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 116
TABLE 95 SPAIN: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 117
TABLE 96 SPAIN: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 117
TABLE 97 REST OF EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 118
TABLE 98 REST OF EUROPE: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 118
TABLE 99 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 120
TABLE 100 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 120
TABLE 101 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (KILOTON) 120
TABLE 102 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (KILOTON) 121
TABLE 103 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2020–2024 (USD MILLION) 121
TABLE 104 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2025–2030 (USD MILLION) 121
TABLE 105 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (USD MILLION) 122
TABLE 106 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (USD MILLION) 122
TABLE 107 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (KILOTON) 122
TABLE 108 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (KILOTON) 123
TABLE 109 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 123
TABLE 110 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 123
TABLE 111 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2020–2024 (USD MILLION) 124
TABLE 112 ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2025–2030 (USD MILLION) 124
TABLE 113 CHINA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 125
TABLE 114 CHINA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 125
TABLE 115 INDIA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 126
TABLE 116 INDIA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 126
TABLE 117 JAPAN: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 127
TABLE 118 JAPAN: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 127
TABLE 119 AUSTRALIA & NEW ZEALAND: TEXTURED VEGETABLE PROTEIN MARKET,
BY APPLICATION, 2020–2024 (USD MILLION) 128
TABLE 120 AUSTRALIA & NEW ZEALAND: TEXTURED VEGETABLE PROTEIN MARKET,
BY APPLICATION, 2025–2030 (USD MILLION) 129
TABLE 121 REST OF ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 129
TABLE 122 REST OF ASIA PACIFIC: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 130
TABLE 123 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 130
TABLE 124 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 131
TABLE 125 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (KILOTON) 131
TABLE 126 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (KILOTON) 131
TABLE 127 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2020–2024 (USD MILLION) 132
TABLE 128 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2025–2030 (USD MILLION) 132
TABLE 129 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (USD MILLION) 132
TABLE 130 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (USD MILLION) 133
TABLE 131 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (KILOTON) 133
TABLE 132 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (KILOTON) 133
TABLE 133 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 134
TABLE 134 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134
TABLE 135 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2020–2024 (USD MILLION) 134
TABLE 136 SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2025–2030 (USD MILLION) 135
TABLE 137 BRAZIL: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 135
TABLE 138 BRAZIL: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 136
TABLE 139 ARGENTINA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 137
TABLE 140 ARGENTINA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 137
TABLE 141 REST OF SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET,
BY APPLICATION, 2020–2024 (USD MILLION) 138
TABLE 142 REST OF SOUTH AMERICA: TEXTURED VEGETABLE PROTEIN MARKET,
BY APPLICATION, 2025–2030 (USD MILLION) 138
TABLE 143 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 139
TABLE 144 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 139
TABLE 145 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2020–2024 (KILOTON) 139
TABLE 146 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY COUNTRY,
2025–2030 (KILOTON) 139
TABLE 147 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2020–2024 (USD MILLION) 140
TABLE 148 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE,
2025–2030 (USD MILLION) 140
TABLE 149 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (USD MILLION) 140
TABLE 150 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (USD MILLION) 141
TABLE 151 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2020–2024 (KILOTON) 141
TABLE 152 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025–2030 (KILOTON) 141
TABLE 153 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 142
TABLE 154 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 142
TABLE 155 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2020–2024 (USD MILLION) 142
TABLE 156 ROW: TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2025–2030 (USD MILLION) 143
TABLE 157 MIDDLE EAST: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 143
TABLE 158 MIDDLE EAST: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 144
TABLE 159 AFRICA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 144
TABLE 160 AFRICA: TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 145
TABLE 161 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TEXTURED VEGETABLE PROTEIN MARKET, 2020–2024 147
TABLE 162 TEXTURED VEGETABLE PROTEIN MARKET: DEGREE OF COMPETITION 150
TABLE 163 TEXTURED VEGETABLE PROTEIN MARKET: TYPE FOOTPRINT 155
TABLE 164 TEXTURED VEGETABLE PROTEIN MARKET: NATURE FOOTPRINT 156
TABLE 165 TEXTURED VEGETABLE PROTEIN MARKET: APPLICATION FOOTPRINT 157
TABLE 166 TEXTURED VEGETABLE PROTEIN MARKET: REGIONAL FOOTPRINT 158
TABLE 167 TEXTURED VEGETABLE PROTEIN MARKET: KEY START-UPS/SMES 161
TABLE 168 TEXTURED VEGETABLE PROTEIN MARKET: COMPETITIVE BENCHMARKING OF
KEY START-UPS/SMES, 2024 162
TABLE 169 TEXTURED VEGETABLE PROTEIN MARKET: PRODUCT LAUNCHES,
JANUARY 2020–MAY 2025 165
TABLE 170 TEXTURED VEGETABLE PROTEIN MARKET: DEALS, JANUARY 2020–MAY 2025 167
TABLE 171 TEXTURED VEGETABLE PROTEIN MARKET: EXPANSIONS,
JANUARY 2020–MAY 2025 168
TABLE 172 ADM: COMPANY OVERVIEW 171
TABLE 173 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 172
TABLE 174 ADM: PRODUCT LAUNCHES 173
TABLE 175 ADM: DEALS 174
TABLE 176 ADM: EXPANSIONS 174
TABLE 177 CARGILL, INCORPORATED: COMPANY OVERVIEW 176
TABLE 178 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 177
TABLE 179 CARGILL, INCORPORATED: PRODUCT LAUNCHES 177
TABLE 180 CARGILL, INCORPORATED: EXPANSIONS 177
TABLE 181 ROQUETTE FRÈRES: COMPANY OVERVIEW 179
TABLE 182 ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 180
TABLE 183 ROQUETTE FRÈRES: PRODUCT LAUNCHES 180
TABLE 184 ROQUETTE FRÈRES: DEALS 181
TABLE 185 ROQUETTE FRÈRES: EXPANSIONS 181
TABLE 186 INTERNATIONAL FLAVOURS & FRAGRANCES INC.: COMPANY OVERVIEW 183
TABLE 187 INTERNATIONAL FLAVOURS & FRAGRANCES INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 184
TABLE 188 INTERNATIONAL FLAVOURS & FRAGRANCES INC.: PRODUCT LAUNCHES 185
TABLE 189 INTERNATIONAL FLAVOURS & FRAGRANCES INC.: DEALS 185
TABLE 190 INGREDION: COMPANY OVERVIEW 187
TABLE 191 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 188
TABLE 192 INGREDION: PRODUCT LAUNCHES 189
TABLE 193 INGREDION: DEALS 189
TABLE 194 DSM-FIRMENICH: COMPANY OVERVIEW 191
TABLE 195 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 192
TABLE 196 DSM-FIRMENICH: PRODUCT LAUNCHES 193
TABLE 197 DSM-FIRMENICH: DEALS 193
TABLE 198 MGP: COMPANY OVERVIEW 194
TABLE 199 MGP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 195
TABLE 200 MGP: PRODUCT LAUNCHES 196
TABLE 201 MGP: EXPANSIONS 196
TABLE 202 PURIS: COMPANY OVERVIEW 198
TABLE 203 PURIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 198
TABLE 204 PURIS: PRODUCT LAUNCHES 199
TABLE 205 PURIS: EXPANSIONS 199
TABLE 206 BENEO: COMPANY OVERVIEW 201
TABLE 207 BENEO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 201
TABLE 208 BENEO: DEALS 202
TABLE 209 BENEO: EXPANSIONS 202
TABLE 210 AXIOM FOODS, INC.: COMPANY OVERVIEW 204
TABLE 211 AXIOM FOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 204
TABLE 212 AXIOM FOODS, INC.: PRODUCT LAUNCHES 205
TABLE 213 THE SCOULAR COMPANY: COMPANY OVERVIEW 206
TABLE 214 THE SCOULAR COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 206
TABLE 215 SHANDONG YUXIN BIO-TECH CO., LTD.: COMPANY OVERVIEW 207
TABLE 216 SHANDONG YUXIN BIO-TECH CO., LTD.:
PRODUCTS/SOLUTIONS/SERVICES OFFERED 207
TABLE 217 GUSHEN BIOLOGICAL TECHNOLOGY GROUP CO., LTD.: COMPANY OVERVIEW 208
TABLE 218 GUSHEN BIOLOGICAL TECHNOLOGY GROUP CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 208
TABLE 219 FOODCHEM INTERNATIONAL CORPORATION: COMPANY OVERVIEW 209
TABLE 220 FOODCHEM INTERNATIONAL CORPORATION:
PRODUCTS/SOLUTIONS/SERVICES OFFERED 209
TABLE 221 DACSA GROUP: COMPANY OVERVIEW 210
TABLE 222 DACSA GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 210
TABLE 223 SHANDONG WONDERFUL BIOTECH CO., LTD.: COMPANY OVERVIEW 212
TABLE 224 SHANDONG WONDERFUL BIOTECH CO., LTD.:
PRODUCTS/SOLUTIONS/SERVICES OFFERED 212
TABLE 225 SUN NUTRAFOODS: COMPANY OVERVIEW 214
TABLE 226 SUN NUTRAFOODS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214
TABLE 227 CROWN SOYA PROTEIN GROUP COMPANY: COMPANY OVERVIEW 215
TABLE 228 CROWN SOYA PROTEIN GROUP COMPANY:
PRODUCTS/SOLUTIONS/SERVICES OFFERED 215
TABLE 229 HOYA FOODS: COMPANY OVERVIEW 216
TABLE 230 HOYA FOODS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 216
TABLE 231 SOTEXPRO: COMPANY OVERVIEW 218
TABLE 232 SOTEXPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 218
TABLE 233 ADJACENT MARKETS TO TEXTURED VEGETABLE PROTEIN 222
TABLE 234 PLANT-BASED PROTEIN MARKET, BY SOURCE, 2019–2023 (USD MILLION) 224
TABLE 235 PLANT-BASED PROTEIN MARKET, BY SOURCE, 2024–2029 (USD MILLION) 224
TABLE 236 PLANT-BASED PROTEIN MARKET, BY SOURCE, 2019–2023 (KILOTON) 225
TABLE 237 PLANT-BASED PROTEIN MARKET, BY SOURCE, 2024–2029 (KILOTON) 225
TABLE 238 PEA PROTEIN MARKET, BY TYPE, 2020–2023 (USD MILLION) 226
TABLE 239 PEA PROTEIN MARKET, BY TYPE, 2024–2029 (USD MILLION) 227
TABLE 240 PEA PROTEIN MARKET, BY TYPE, 2020–2023 (KILOTON) 227
TABLE 241 PEA PROTEIN MARKET, BY TYPE, 2024–2029 (KILOTON) 227
TABLE 242 MEAT SUBSTITUTES MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 228
TABLE 243 MEAT SUBSTITUTES MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 228
LIST OF FIGURES
FIGURE 1 MARKET SEGMENTATION AND REGIONAL SCOPE 26
FIGURE 2 TEXTURED VEGETABLE PROTEIN MARKET: RESEARCH DESIGN 31
FIGURE 3 TEXTURED VEGETABLE PROTEIN MARKET: DEMAND-SIDE CALCULATION 36
FIGURE 4 TEXTURED VEGETABLE PROTEIN MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 37
FIGURE 5 TEXTURED VEGETABLE PROTEIN MARKET SIZE ESTIMATION STEPS AND RESPECTIVE SOURCES: SUPPLY SIDE 38
FIGURE 6 TEXTURED VEGETABLE PROTEIN MARKET: DATA TRIANGULATION 39
FIGURE 7 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025 VS. 2030 (USD MILLION) 42
FIGURE 8 TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 42
FIGURE 9 TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 43
FIGURE 10 TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2025 VS. 2030 (USD MILLION) 43
FIGURE 11 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 44
FIGURE 12 GROWING AWARENESS OF HEALTH BENEFITS OF PLANT-BASED PROTEIN TO DRIVE MARKET 45
FIGURE 13 SOY SEGMENT & US TO ACCOUNT FOR LARGEST SHARES IN NORTH AMERICAN MARKET IN 2025 46
FIGURE 14 SOY TO ACCOUNT FOR LARGEST MARKET IN TERMS OF VOLUME DURING FORECAST PERIOD 46
FIGURE 15 SOY SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES DURING FORECAST PERIOD 47
FIGURE 16 US TO ACCOUNT FOR LARGEST MARKET SHARE (BY VALUE) IN 2025 48
FIGURE 17 GLOBAL PRODUCTION OF CHICKPEAS AND GREEN PEAS,
2018–2022 (MILLION TONNES) 49
FIGURE 18 GLOBAL PEA PRODUCTION, BY COUNTRY, 2021 (MILLION TONNES) 50
FIGURE 19 US PLANT-BASED MARKET, 2019–2022 (BILLION) 51
FIGURE 20 TEXTURED VEGETABLE PROTEIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
FIGURE 21 PLANT-BASED MEAT AND SEAFOOD PRODUCT CATEGORY, 2023 53
FIGURE 22 AVERAGE UNIT PRICES OF PLANT-BASED VS. ANIMAL-BASED PRODUCTS BY CATEGORY, 2020 56
FIGURE 23 ADOPTION OF GEN AI IN F00D & BEVERAGE PRODUCTION PROCESS 59
FIGURE 24 TEXTURED VEGETABLE PROTEIN MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 63
FIGURE 25 TEXTURED VEGETABLE PROTEIN MARKET, BY SOURCE,
2025 VS. 2030 (USD MILLION) 70
FIGURE 26 TEXTURED VEGETABLE PROTEIN MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 81
FIGURE 27 TOTAL US PLANT-BASED PRODUCT SALES, 2023 (USD BILLION) 86
FIGURE 28 TEXTURED VEGETABLE PROTEIN MARKET, BY NATURE,
2025 VS. 2030 (USD MILLION) 90
FIGURE 29 CHINA TO GROW AT HIGHEST RATE DURING FORECAST PERIOD 95
FIGURE 30 NORTH AMERICA: MARKET SNAPSHOT 98
FIGURE 31 ASIA PACIFIC: MARKET SNAPSHOT 119
FIGURE 32 TEXTURED VEGETABLE PROTEIN MARKET: REVENUE ANALYSIS OF KEY PLAYERS 2020–2024 (USD BILLION) 149
FIGURE 33 TEXTURED VEGETABLE PROTEIN MARKET: MARKET SHARE ANALYSIS 150
FIGURE 34 TEXTURED VEGETABLE PROTEIN MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 153
FIGURE 35 TEXTURED VEGETABLE PROTEIN MARKET: COMPANY FOOTPRINT 154
FIGURE 36 TEXTURED VEGETABLE PROTEIN MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024 160
FIGURE 37 COMPANY VALUATION OF KEY VENDORS, 2024 (USD BILLION) 163
FIGURE 38 EV/EBITDA OF KEY COMPANIES, 2024 163
FIGURE 39 BRAND/PRODUCT COMPARISON 164
FIGURE 40 ADM: COMPANY SNAPSHOT 172
FIGURE 41 CARGILL, INCORPORATED: COMPANY SNAPSHOT 176
FIGURE 42 INTERNATIONAL FLAVOURS & FRAGRANCES INC.: COMPANY SNAPSHOT 184
FIGURE 43 INGREDION: COMPANY SNAPSHOT 188
FIGURE 44 DSM-FIRMENICH: COMPANY SNAPSHOT 192
FIGURE 45 MGP: COMPANY SNAPSHOT 195
MarketsandMarkets(マーケッツアンドマーケッツ)は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- インタラクティブキオスク市場規模、シェア、動向、2030年までの世界予測 2025-11-07
- 精密林業市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- フィールドサービス管理市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- 採血装置市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- 車載半導体市場規模、シェア、動向、2030年までの世界予測 2025-11-04